Radiosynthesis and preclinical evaluation of [18F]6-fluoro-marsanidine - potential α2A-adrenoceptor tracer.

被引:0
|
作者
Krzyczmonik, Anna [1 ]
Keller, Thomas [1 ]
Lopez-Picon, Francisco [2 ]
Forsback, Sarita [1 ]
Kirjavainen, Anna [1 ]
Wasilewska, Aleksandra [3 ]
Scheinin, Mika [4 ,5 ]
Haaparanta-Solin, Merja [2 ]
Saczewski, Franciszek [3 ]
Solin, Olof [1 ]
机构
[1] Univ Turku, Turku PET Ctr, Radiopharmaceut Chem Lab, Turku, Finland
[2] Univ Turku, Turku PET Ctr, MediCity PET Preclin Lab, Turku, Finland
[3] Med Univ Gdansk, Dept Chem Technol Drugs, Gdansk, Poland
[4] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland
[5] Turku Univ Hosp, Clin Pharmacol Unit, FIN-20520 Turku, Finland
关键词
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
208
引用
收藏
页码:S208 / S208
页数:1
相关论文
共 50 条
  • [11] Radiosynthesis and evaluation of [18F]AFM, a selective PET tracer for the serotonin transporter.
    Huang, Y
    Bac, SA
    Zhu, Z
    Hwang, DR
    Narendran, R
    Talbot, PS
    Hackett, E
    Kegeles, LS
    Laruelle, M
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 358P - 358P
  • [12] Radiosynthesis and evaluation of [18F]MTP: A potential COX-2 PET ligand
    Prabhakaran, Jaya
    Kumar, Dileep
    Simpson, Norman
    Kim, Jongho
    Castrillon, John
    Molotkov, Andrei
    Doubrovin, Mikhail
    Mann, J.
    Mintz, Akiva
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [13] Efficient radiosynthesis and preclinical evaluation of [18F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging
    Singleton, Thomas A.
    Bdair, Hussein
    Bailey, Justin J.
    Choi, Sangho
    Aliaga, Arturo
    Rosa-Neto, Pedro
    Schirrmacher, Ralf
    Bernard-Gauthier, Vadim
    Kostikov, Alexey
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2020, 63 (03): : 144 - 150
  • [14] Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC)
    Henriksen, G
    Herz, M
    Hauser, A
    Schwaiger, M
    Wester, HJ
    NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (07) : 851 - 858
  • [15] Evaluation of 2-deoxy-2-[18F]fluoro glucaric acid (FGA) as a potential PET tracer for tumor necrosis
    Li, Junling
    Zheng, Huaiyu
    Vega, Alexis A.
    Beverly, Levi J.
    Gray, Brian D.
    Pak, Koon Y.
    Ng, Chin K.
    APPLIED RADIATION AND ISOTOPES, 2023, 200
  • [16] Automated radiosynthesis and preclinical in vivo evaluation of [18F] Fluoroethylpuromycin as a potential radiotracer for imaging protein synthesis with PET
    Ramakrishnan, Nisha K.
    Betts, Helen M.
    Sephton, Selena Milicevic
    Zhou, Xiaoyun
    Williamson, David J.
    Sawiak, Stephen
    Aigbirhio, Franklin I.
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114-115 : 71 - 77
  • [17] Radiosynthesis of 6-[18F]Fluoro-α-methyl-L-tryptophan - a prospective tracer for in vivo studies of tryptophan metabolism
    Vazquez-Romero, A.
    Revunov, E.
    Krasikova, R.
    Moein, M. M.
    Cervenka, S.
    Erhardt, S.
    Halldin, C.
    Schou, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S522 - S522
  • [18] A three-step radiosynthesis of 6-[18F]fluoro-L-meta-tyrosine starting with [18F]fluoride
    Melean, Johnny Castillo
    Ermert, Johannes
    Coenen, Heinz H.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 (03): : 133 - 140
  • [19] Preclinical evaluation of 2-[18F]fluorodeoxysorbitol as a tracer for targeted imaging of Enterobacterales infection
    Braams, Lisanne M.
    Sijbesma, Jurgen W. A.
    Boersma, Hendrikus H.
    van Dijl, Jan Maarten
    Elsinga, Philip H.
    Glaudemans, Andor W. J. M.
    Slart, Riemer H. J. A.
    van Oosten, Marleen
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2023, 313 (03)
  • [20] Radiosynthesis and Preclinical Evaluation of m-[18F]FET and [18F]FET-OMe as Novel [18F]FET Analogs for Brain Tumor Imaging
    Groener, Benedikt
    Hoffmann, Chris
    Endepols, Heike
    Urusova, Elizaveta A.
    Brugger, Melanie
    Neumaier, Felix
    Timmer, Marco
    Neumaier, Bernd
    Zlatopolskiy, Boris D.
    MOLECULAR PHARMACEUTICS, 2024, 21 (06) : 2795 - 2812